US Tech 100

17,994.40

-0.19%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
USOTC
Impel Pharmaceuticals Inc (PK) (IMPL)
Impel Pharmaceuticals Inc (PK) (IMPL) News

IMPL

Impel Pharmaceuticals (PK) (IMPL)

Impel Pharmaceuticals Inc (PK)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:IMPL

Date	Time	Source	Headline	Symbol	Company
03/26/2024	3:24PM	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	USOTC:IMPL	Impel Pharmaceuticals Inc (PK)
03/12/2024	7:43AM	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:IMPL	Impel Pharmaceuticals Inc (PK)
12/20/2023	5:08AM	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:IMPL	Impel Pharmaceuticals Inc (PK)
12/19/2023	5:00PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:IMPL	Impel Pharmaceuticals Inc (PK)
05/15/2009	9:39AM	Edgar (US Regulatory)	Notification that Quarterly Report will be submitted late (NT 10-Q)	USOTC:IMPL	Impel Pharmaceuticals Inc (PK)
05/08/2009	8:10AM	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:IMPL	Impel Pharmaceuticals Inc (PK)
04/17/2009	3:13PM	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:IMPL	Impel Pharmaceuticals Inc (PK)
04/14/2009	3:07PM	Edgar (US Regulatory)	Annual Report (10-K)	USOTC:IMPL	Impel Pharmaceuticals Inc (PK)
04/14/2009	1:01PM	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:IMPL	Impel Pharmaceuticals Inc (PK)
03/23/2009	8:22AM	Edgar (US Regulatory)	Amended Current report filing (8-K/A)	USOTC:IMPL	Impel Pharmaceuticals Inc (PK)
03/17/2009	4:23PM	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:IMPL	Impel Pharmaceuticals Inc (PK)
12/19/2008	1:00PM	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:IMPL	Impel Pharmaceuticals Inc (PK)
11/07/2008	1:11PM	Edgar (US Regulatory)	Notification that Quarterly Report will be submitted late (NT 10-Q)	USOTC:IMPL	Impel Pharmaceuticals Inc (PK)